Learn How New Strategies Are Accelerating Preclinical Timelines in This On-Demand Webinar
Researchers are finding new ways to cut through the biggest obstacles to preclinical development timelines. In this on-demand webinar, WuXi Biologics’ VP, CMC Management (US), Xuejun (Sherry) Gu, PhD, and WuXi AppTec’s Executive Director and Global Head of Bioanalytical Services, Jing Shi, PhD, look at how biologics developers are advancing large molecule therapies with the help of new preclinical program strategies.
WuXi AppTec Bioanalytical Services
WuXi AppTec is a global leader in preclinical drug development testing and world-class expert in bioanalysis. We are a full-service partner, acting as an extension of your team and providing end-to-end testing services and regulatory support.
- 500+ active clients
- 500+ bioanalytical staff
- 2,000+ global clinical trials supported
- 1 million+ bioanalytical samples analyzed per year
- 150+ novel compounds supported per year